Thies. Acta Neuropathol. 2011, 121, 337?49.Int. J. Mol. Sci. 2014,115. Thornton, C.; Bright, N.J.; Sastre, M.; Muckett, P.J.; Carling, D. AMP-activated protein kinase (AMPK) can be a tau kinase, activated in response to amyloid -peptide exposure. Biochem. J. 2011, 434, 503?12. 116. Timm, T.; Marx, A.; Panneerselvam, S.; Mandelkow, E.; Mandelkow, E.M. Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein. BMC Neurosci. 2008, 2, S9. 117. Chin, J.Y.; Knowles, R.B.; Schneider, A.; Drewes, G.; Mandelkow, E.M.; Hyman, B.T. Microtubule-affinity regulating kinase (MARK) is tightly related to neurofibrillary tangles in Alzheimer brain: A fluorescence resonance power transfer study. J. Neuropathol. Exp. Neurol. 2000, 59, 966?71.6-Bromo-8-fluoroisoquinoline Order 118. Gustke, N.; Steiner, B.; Mandelkow, E.M.; Biernat, J.; Meyer, H.E.; Goedert, M.; Mandelkow, E. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and entails Ser-Pro and Thr-Pro motifs. FEBS Lett. 1992, 307, 199?05. 119. Augustinack, J.C.; Sanders, J.L.; Tsai, L.H.; Hyman, B.T. Colocalization and fluorescence resonance power transfer among cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 2002, 61, 557?64. 120. Augustinack, J.C.; Schneider, A.; Mandelkow, E.M.; Hyman, B.T. Precise tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease. Acta Neuropathol. 2002, 103, 26?five. 121. Mocanu, M.M.; Nissen, A.; Eckermann, K.; Khlistunova, I.; Biernat, J.; Drexler, D.; Petrova, O.; Sch ig, K.; Bujard, H.; Mandelkow, E.; et al. The prospective for beta-structure within the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 2008, 28, 737?48. 122. Gu, G.J.; Lund, H.; Wu, D.; Blokzijl, A.; Classon, C.(5-Methylthiophen-2-yl)methanol Order ; von Euler, G.; Landegren, U.; Sunnemark, D.; Kamali-Moghaddam, M. Function of person MARK isoforms in phosphorylation of tau at Ser262 in Alzheimer illness. Neuromol. Med. 2013, 15, 458?69. 123. Wu, P.R.; Tsai, P.I.; Chen, G.C.; Chou, H.J.; Huang, Y.P.; Chen, Y.H.; Lin, M.Y.; Kimchi, A.; Chien, C.T.; Chen, R.H. DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity.PMID:33527856 Cell Death Differ. 2011, 18, 1507?520. 124. Sun, L.; Wang, X.; Liu, S.; Wang, Q.; Wang, J.; Bennecib, M.; Gong, C.X.; Sengupta, A.; Grundke-Iqbal, I.; Iqbal, K. Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat. FEBS Lett. 2005, 579, 251?58. 125. Liu, F.; Liang, Z.; Shi, J.; Yin, D.; El-Akkad, E.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners. FEBS Lett. 2006, 580, 6269?274. 126. Liu, F.; Li, B.; Tung, E.J.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation. Eur. J. Neurosci. 2007, 26, 3429?436. 127. Liu, S.J.; Zhang, J.Y.; Li, H.L.; Fang, Z.Y., Wang, Q.; Deng, H.M.; Gong, C.X.; Grundke-Iqbal, I.; Iqbal, K.; Wang, J.Z. Tau becomes a more favorable substrate for GSK-3 when it is actually prephosphorylated by PKA in rat brain. J. Biol. Chem. 2004, 279, 50078?0088.Int. J. Mol. Sci. 2014,128. Arioka, M.; Tsukamoto, M.; Ishiguro, K.; Kato, R.; Sato, K.; Ima.